Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Periprosthetic Joint Infection in Patients with Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
Antoninus Hengky1,2, Malvin Tandry2, Kevin Gracia Pratama2
1Center of Health Research, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Abstract:
Periprosthetic joint infection (PJI) represents a significant obstacle within the realm of orthopedic procedures. Certain medical conditions, such as benign prostatic hyperplasia (BPH) which causes blockages in the lower urinary system, have been suggested as potential PJI contributing factors. Nevertheless, the available evidence remains inconclusive regarding these associations. For enhancing treatment strategies and ultimately improving results achieved by individuals receiving care, gaining a better understanding of these relationships is imperative. All in accordance with the PRISMA 2020 guidelines, an indepth analysis was conducted utilizing structured and methodical review techniques, involving manual searches as well as databases like PubMed, EBSCO, and ProQuest. This review specifically included studies that provided information on both BPH and PJI. Through a meta-analytical approach, the data evaluation was conducted employing a random-effects framework. This process was facilitated by the use of Comprehensive Meta-Analysis software, version 3. Five research articles were analyzed, collectively revealing no meaningful correlation between BPH and an elevated likelihood of PJI, as indicated by the odds ratio (OR 1.228, 95% confidence interval [CI] 0.914-1.649, P=0.172). Moreover, no significant associations were yielded through further analyses for BPH studies for either total hip arthroplasty (OR 1.138, 95% CI 0.793-1.635, P=0.483) or total knee arthroplasty (OR 2.429, 95% CI 0.240-24.584, P=0.452) surgery. No association was substantiated between BPH and the incidence of PJI. It is possible that other factors, such as infections which are more likely to occur in individuals with BPH, could influence PJI rates.
Insights
This study found no significant link between benign prostatic hyperplasia (BPH) and periprosthetic joint infection (PJI). Further research is needed to understand potential indirect influences on PJI risk in patients with BPH.
Area of Science:
- Orthopedic Surgery
- Urology
- Infectious Diseases
Background:
- Periprosthetic joint infection (PJI) is a major complication in orthopedic surgery.
- Benign prostatic hyperplasia (BPH) is a common condition affecting the lower urinary system.
- A potential association between BPH and PJI has been suggested but lacks conclusive evidence.
Purpose of the Study:
- To investigate the relationship between benign prostatic hyperplasia (BPH) and the risk of periprosthetic joint infection (PJI).
- To synthesize existing evidence through a meta-analysis to clarify the association between BPH and PJI incidence.
Main Methods:
- A systematic review and meta-analysis were conducted following PRISMA 2020 guidelines.
- Literature searches were performed on PubMed, EBSCO, and ProQuest databases.
- Data from five studies were analyzed using a random-effects model with Comprehensive Meta-Analysis software.
Main Results:
- The meta-analysis revealed no statistically significant correlation between BPH and an increased likelihood of PJI (OR 1.228, P=0.172).
- Subgroup analyses for total hip arthroplasty and total knee arthroplasty also showed no significant associations.
- No direct link was substantiated between BPH and PJI incidence.
Conclusions:
- Benign prostatic hyperplasia (BPH) is not directly associated with an elevated risk of periprosthetic joint infection (PJI).
- Other factors, potentially related to infections common in BPH patients, might influence PJI rates.
- Further research is warranted to explore indirect relationships and confounding variables.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

